Your browser doesn't support javascript.
loading
Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.
Ashina, Messoud; Lanteri-Minet, Michel; Pozo-Rosich, Patricia; Ettrup, Anders; Christoffersen, Cecilie Laurberg; Josiassen, Mette Krog; Phul, Ravinder; Sperling, Bjørn.
Afiliação
  • Ashina M; Danish Headache Center, Rigshospitalet Glostrup, University of Copenhagen, Copenhagen, Denmark. Electronic address: ashina@dadlnet.dk.
  • Lanteri-Minet M; Pain Department and FHU InovPain, Centre Hospitalier Universitaire de Nice, Nice, France; INSERM U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, France.
  • Pozo-Rosich P; Headache Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Department de Medicina, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Ettrup A; H Lundbeck, Copenhagen, Denmark.
  • Christoffersen CL; H Lundbeck, Copenhagen, Denmark.
  • Josiassen MK; H Lundbeck, Copenhagen, Denmark.
  • Phul R; H Lundbeck, Copenhagen, Denmark.
  • Sperling B; H Lundbeck, Copenhagen, Denmark.
Lancet Neurol ; 21(7): 597-607, 2022 07.
Article em En | MEDLINE | ID: mdl-35716692
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article